Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aadi Bioscience, Inc. (AADI)

14.2   0.09 (0.64%) 08-07 23:48
Open: 13.96 Pre. Close: 14.11
High: 14.35 Low: 13.78
Volume: 83,472 Market Cap: 297(M)
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.24 - 14.29 14.29 - 14.34
Low: 13.48 - 13.54 13.54 - 13.6
Close: 14.01 - 14.1 14.1 - 14.18

Technical analysis

as of: 2022-08-05 4:19:52 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 16.76     One year: 19.57
Support: Support1: 12.9    Support2: 12.01
Resistance: Resistance1: 14.35    Resistance2: 16.76
Pivot: 12.99
Moving Average: MA(5): 13.53     MA(20): 12.98
MA(100): 14.68     MA(250): 20.36
MACD: MACD(12,26): 0     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 85.6     %D(3): 79.3
RSI: RSI(14): 61.2
52-week: High: 40.2  Low: 11
Average Vol(K): 3-Month: 153 (K)  10-Days: 150 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ AADI ] has closed above the upper band by 3.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 Aug 2022
What is the Market's View on Aadi Bioscience Inc (AADI) Stock's Price and Volume Trends Wednesday? - InvestorsObserver

Wed, 03 Aug 2022
Aadi Perukku celebrated with traditional gaiety, as Cauvery brims - The Hindu

Tue, 02 Aug 2022
Watch: Sea of devotees participate in Aadi Pooram chariot festival of Srivilliputhur Temple in Tamil Nadu - Economic Times

Mon, 01 Aug 2022
Aadi Pooram, the birth of Andal and baby shower of Ma Parvati - HinduPost

Fri, 29 Jul 2022
Zilingo COO Aadi Vaidya quits in latest blow for Singapore startup - The Economic Times

Fri, 29 Jul 2022
Singapore's Zilingo COO Aadi Vaidya Resigns - Bloomberg

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. -41 (M)
Shares Float 0 (M)
% Held by Insiders 2.094e+007 (%)
% Held by Institutions 1.5e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.855e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -8.82
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 414.8
Return on Equity (ttm) -37.1
Qtrly Rev. Growth 3.31e+006
Gross Profit (p.s.) -0.03
Sales Per Share 0.68
EBITDA (p.s.) -0.61
Qtrly Earnings Growth -4.661e+007
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value -1.62
Price to Sales 20.78
Price to Cash Flow 0

Stock Dividends

Dividend 752240
Forward Dividend 784370
Dividend Yield 5297460%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.